Decreased visual field sensitivity measured 1 day, then 1 week, after migraine

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 4, 2004, Pages 1061-1070

  McKendrick, Allison M ^a   Badcock, David R ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOANALYSIS; CLINICAL ARTICLE; CLINICAL RESEARCH; COMPUTER ASSISTED PERIMETRY; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; HUMAN; MIGRAINE; PERFORMANCE; PERIMETER; POPULATION; PRIORITY JOURNAL; VISUAL FIELD; ADOLESCENT; MIDDLE AGED; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; PATHOPHYSIOLOGY; PERIMETRY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TIME; VISUAL DISORDER;

ADOLESCENT; ADULT; HUMANS; MIDDLE AGED; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; PERIMETRY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; VISION DISORDERS; VISUAL FIELDS;

EID: 2142702296     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0936     Document Type: Article

References (42)

1. Lewis RA, Vijayan N, Watson C, Keltner J, Johnson CA. Visual field loss in migraine. Ophthalmology. 1989;96:321-326.
2. De Natale R, Polimeni D, Narbone MC, Scullica MG, Pelicano M. Visual field defects in migraine patients. In: Mills RP, ed. Perimetry Update 93/94. Amsterdam: Kugler 1994:283-284.
3. Comoglu S, Yarangumeli A, Koz OG, Elhan AH, Kural G. Glaucomatous visual field defects in patients with migraine. J Neurol. 2003;250:201-206.
4. McKendrick AM, Vingrys AJ, Badcock DR, Heywood JT. Visual field losses in subjects with migraine headaches. Invest Ophthalmol Vis Sci. 2000;41:1239-1247.
5. McKendrick AM, Cioffi GA, Johnson CA. Short wavelength sensitivity deficits in patients with migraine. Arch Ophthalmol. 2002;120:154-161.
6. Cursiefen C, Wisse M, Cursiefen S, Junemann A, Martus P, Korth M. Migraine and tension headache in high-pressure and normal-pressure glaucoma. Am J Ophthalmol. 2000;129:102-104.
7. Phelps CD, Corbett JJ. Migraine and low-tension glaucoma: a case-control study. Invest Ophthalmol Vis Sci. 1985;26:1105-1108.
8. Wang JJ, Mitchell P, Smith W. Is there an association between migraine headache and open-angle glaucoma? Findings from the Blue Mountains Eye Study. Ophthalmology. 1997;104:1714-1719.
9. Corbett JJ, Phelps CD, Eslinger P, Montague PR. The neurologic evaluation of patients with low-tension glaucoma. Invest Ophthalmol Vis Sci. 1985;26:1101-1104.
10. Klein BE, Klein R, Meuer SM, Goetz LA. Migraine headache and its association with open-angle glaucoma: the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci. 1993;34:3024-3027.
11. Usui T, Iwata K, Shirakashi M, Abe H. Prevalence of migraine in low-tension glaucoma and primary open-angle glaucoma in Japanese. Br J Ophthalmol. 1991;75:224-226.
12. Flammer J, Pache M, Resnik T. Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res. 2001;20:319-349.
13. Drance S, Anderson DR, Schulzer M. Risk factors for progression of visual field abnormalities in normal-tension glaucoma. Am J Ophthalmol. 2001;131:699-708.
14. Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence: a review of population based studies. Neurology. 1994;44(suppl 4):S17-S23.
15. McKendrick AM, Vingrys AJ, Badcock DR, Heywood JT. Visual dysfunction between migraine events. Invest Ophthalmol Vis Sci. 2001;42:626-633.
16. Mitchell P, Smith W, Attebo K, Healey PR. Prevalence of open-angle glaucoma in Australia, The Blue Mountains Eye Study. Ophthalmology. 1996;103:1661-1669.
17. Klein BE, Klein R, Sponsel WE, et al. Prevalence of glaucoma: the Beaver Dam Eye Study. Ophthalmology. 1992;99:1499-1504.
18. Drummond PD, Anderson M. Visual field loss after attacks of migraine with aura. Cephalalgia. 1992;12:349-352.
19. Sullivan-Mee M, Bowman B. Migraine-related visual-field loss with prolonged recovery. J Am Optom Assoc. 1997;68:377-388.
20. International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(suppl),7.
21. Vingrys AJ, Helfrich KA. The Opticom M-600: a new LED automated perimeter. Clin Exp Optom. 1990;1:10-20.
22. Landers J, Sharma A, Goldberg I, Graham S. A comparison of perimetric results with the Medmont and Humphrey perimeters. Br J Ophthalmol. 2003;87:690-694.
23. King-Smith P, Grigsby S, Vingrys AJ, Benes S, Supowit A. Efficient and unbiased modifications of the QUEST threshold method: theory, simulations, experimental evaluation, and practical implementation. Vision Res. 1994;34:885-912.
24. Russell MB, Olesen J. A nosographic analysis of the migraine aura in a general population. Brain. 1996;119:355-361.
25. Artes PH, Iwase A, Ohno Y, Kitazawa Y, Chauhan BC. Properties of perimetric threshold estimates from Full Threshold, SITA Standard, and SITA Fast strategies. Invest Ophthalmol Vis Sci. 2002;43:2654-2659.
26. Wild JM, Pacey IE, O'Neill EC, Cunliffe IA. The SITA perimetric threshold algorithms in glaucoma. Invest Ophthalmol Vis Sci. 1999;40:1998-2009.
27. McKendrick AM, Badcock DR. Contrast-processing dysfunction in both magnocellular and parvocellular pathways in migraineurs both with and without aura. Invest Ophthalmol Vis Sci. 2003;44:442-448.
28. Goadsby PJ, Lipton RB, Ferrari MD. Migraine: current understanding and treatment. N Engl J Med. 2002;346:257-269.
29. Gasser P, Meienberg O. Finger microcirculation in classical migraine, Eur Neurol. 1991;31:168-171.
30. Hegyalijai T, Meienberg O, Dubler B, Gasser P. Cold-induced acral vasospasm in migraine as assessed by nailfold video-microscopy: prevalence and response to migraine prophylaxis. Angiology. 1997;48:345-349.
31. Broadway DC, Drance SM. Glaucoma and vasospasm. Br J Ophthalmol. 1998;82:862-870.
32. Nicolela MT, Ferrier SN, Morrison CA, et al. Effects of cold-induced vasospasm in glaucoma: the role of endothelin-1. Invest Ophthalmol Vis Sci. 2003;44:2565-2572.
33. Kallela M, Farkkila M, Saijonmaa O, Fyhrquist F. Endothelin in migraine patients. Cephalalgia. 1998;18:329-332.
34. Tzourio C, El Amrani M, Poirer O, Nicaud V, Bousser M-G, Alperovitch A. Association between migraine and endothelin type A receptor (ETA-231 A/G) gene polymorphism. Neurology. 2001;56:1273-1277.
35. Casson EJ, Johnson CA, Shapiro LR. Longitudinal comparison of temporal-modulation perimetry with white-on-white and blue-on-yellow perimetry in ocular hypertension and early glaucoma. J Opt Soc Am A Opt Image Sci Vis. 1993;10:1792-1806.
36. Sample PA, Bosworth CF, Blumenthal EZ, Girkin C, Weinreb RN. Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma. Invest Ophthalmol Vis Sci. 2000;41:1783-1790.
37. Sample PA, Bosworth CF, Weinreb RN. Short-wavelength automated perimetry and motion automated perimetry in patients with glaucoma. Arch Ophthalmol. 1997;115:1129-1133.
38. Johnson CA, Samuels SJ. Screening for glaucomatous visual field loss with frequency-doubling perimetry. Invest Ophthalmol Vis Sci. 1997;38:413-425.
39. Johnson CA, Adams AJ, Casson EJ, Brandt JD, Progression of early glaucomatous visual field loss for blue-on-yellow and standard white-on-white automated perimetry. Arch Ophthalmol. 1993;111:651-656.
40. Quigley HA, Dunkelberger GR, Green WR. Chronic human glaucoma causing selectively greater loss of large optic nerve fibers. Ophthalmology. 1988;95:357-363.
41. Glovinsky Y, Quigley HA, Dunkelberger GR. Retinal ganglion cell loss is size dependent in experimental glaucoma. Invest Ophthalmol Vis Sci. 1991;32:484-491.
42. Johnson CA. Selective versus nonselective losses in glaucoma. J Glaucoma. 1994;3:S32-S44.